ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

A&K Pharma Limited

A&K Pharma Limited is an active company incorporated on 10 January 2020 with the registered office located in Dudley, West Midlands. A&K Pharma Limited was registered 5 years ago.
Status
Active
Active since incorporation
Company No
12397803
Private limited company
Age
5 years
Incorporated 10 January 2020
Size
Micro
Turnover is under £1M
Under 10 employees
Confirmation
Submitted
Dated 9 January 2025 (10 months ago)
Next confirmation dated 9 January 2026
Due by 23 January 2026 (2 months remaining)
No changes occurred since incorporation
Accounts
Submitted
For period 1 Apr31 Mar 2024 (1 year)
Accounts type is Micro Entity
Next accounts for period 31 March 2025
Due by 31 December 2025 (1 month remaining)
Address
Unit 1 Castle Court 2
Castle Gate Way
Dudley
DY1 4RH
United Kingdom
Address changed on 15 Jan 2025 (9 months ago)
Previous address was 148 Rugby Avenue Wembley HA0 3DP England
Telephone
Unreported
Email
Unreported
People
Officers
2
Shareholders
2
Controllers (PSC)
2
PSC • Director • British • Lives in England • Born in Mar 1988
Director • British • Lives in UK • Born in Aug 1984
Mr Aryuat Rupchitya Patel
PSC • British • Lives in UK • Born in Aug 1984
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Yaahvi Limited
Komal Patel and Aryuat Rupchitya Patel are mutual people.
Active
Fairbrothers Limited
Komal Patel and Aryuat Rupchitya Patel are mutual people.
Active
ARK Pharm Limited
Komal Patel and Aryuat Rupchitya Patel are mutual people.
Active
Kara Pharma Limited
Komal Patel and Aryuat Rupchitya Patel are mutual people.
Active
Chemicrest Limited
Aryuat Rupchitya Patel is a mutual person.
Active
Fairbrother Pharmacy Limited
Aryuat Rupchitya Patel is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2021–2024)
Period Ended
31 Mar 2024
For period 31 Mar31 Mar 2024
Traded for 12 months
Cash in Bank
Unreported
Decreased by £94.27K (-100%)
Turnover
Unreported
Same as previous period
Employees
2
Same as previous period
Total Assets
£1.62M
Increased by £227.93K (+16%)
Total Liabilities
-£941.48K
Increased by £186.87K (+25%)
Net Assets
£677.26K
Increased by £41.06K (+6%)
Debt Ratio (%)
58%
Increased by 3.9% (+7%)
Latest Activity
Confirmation Submitted
9 Months Ago on 16 Jan 2025
Registered Address Changed
9 Months Ago on 15 Jan 2025
Micro Accounts Submitted
10 Months Ago on 23 Dec 2024
Confirmation Submitted
1 Year 10 Months Ago on 9 Jan 2024
Full Accounts Submitted
1 Year 10 Months Ago on 18 Dec 2023
Confirmation Submitted
2 Years 10 Months Ago on 9 Jan 2023
Full Accounts Submitted
3 Years Ago on 20 Sep 2022
Full Accounts Submitted
3 Years Ago on 19 Jan 2022
Confirmation Submitted
3 Years Ago on 17 Jan 2022
Accounting Period Extended
4 Years Ago on 28 Sep 2021
Get Credit Report
Discover A&K Pharma Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Confirmation statement made on 9 January 2025 with no updates
Submitted on 16 Jan 2025
Registered office address changed from 148 Rugby Avenue Wembley HA0 3DP England to Unit 1 Castle Court 2 Castle Gate Way Dudley DY1 4RH on 15 January 2025
Submitted on 15 Jan 2025
Micro company accounts made up to 31 March 2024
Submitted on 23 Dec 2024
Confirmation statement made on 9 January 2024 with no updates
Submitted on 9 Jan 2024
Total exemption full accounts made up to 31 March 2023
Submitted on 18 Dec 2023
Confirmation statement made on 9 January 2023 with no updates
Submitted on 9 Jan 2023
Total exemption full accounts made up to 31 March 2022
Submitted on 20 Sep 2022
Total exemption full accounts made up to 31 March 2021
Submitted on 19 Jan 2022
Confirmation statement made on 9 January 2022 with no updates
Submitted on 17 Jan 2022
Previous accounting period extended from 31 January 2021 to 31 March 2021
Submitted on 28 Sep 2021
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year